• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LOMBARD MEDIAL LTD AORTIX AAA FLEXIBLE STENT GRAFT SYSTEM; ENDOVASCULAR STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LOMBARD MEDIAL LTD AORTIX AAA FLEXIBLE STENT GRAFT SYSTEM; ENDOVASCULAR STENT GRAFT Back to Search Results
Model Number SG-HBB-27-96-63-12
Device Problem No Apparent Adverse Event (3189)
Patient Problems Aneurysm (1708); Death (1802)
Event Date 05/20/2015
Event Type  Death  
Event Description
The original procedure was performed on a very small (b)(6) female patient, weight (b)(6) who had been admitted to the hospital the morning of the procedure with a chronically symptomatic aneurysm and who was unsuitable for open repair of her aaa.Her symptoms included gastric obstruction secondary to the aaa.Her aortic anatomy involved an unfavourable aneurysm neck that was angled 80 degrees, included a dissection flap, was highly conical and had an overall length of less than 15mm.The diameter of the aneurysm was 12cm an access vessels had luminal diameters of 6mm which is smaller than the size of the aorfix delivery system.A decision was taken to treat the patient's aneurysm as an emergency an aorfix was chosen because of the high neck angle but despite the short and conical neck lying outside the indications for the implant.Notes on the patient were not available but after completion of the surgery the patient's family revealed a history of extensive peripheral arterial disease.(internal reference number: (b)(4)).During the procedure aorfix was placed as juxta-renally as possible to maximise the available neck.During the procedure it was noted that the right external iliac artery had been perforated and eventually this was ligated after attempts failed to re-line the vessel with covered stents.A fem-fem bypass graft was placed to maintain perfusion of the right femoral artery system.Great difficulty was encountered with several aspects of the surgery indicated by the overall procedure lasting over 15 hours.The surgeon commented that the evar part of the procedure lasted approximately 3 of the 15 hours and the remaining 12 hours involved resolving occlusions and perforations to the vasculature consequent to the very poor condition of the patient's vessels.A completion angiogram showed that there was a type ia endoleak which reduced on repeat ballooning but was not fully resolved.A total of 370ml of contrast agent was administered to the patient.The patient survived the procedure but died on the itu 3 days post procedure from renal failure consequent to contrast nephrotoxicity.The surgeon commented that aorfix performed perfectly but unfortunately the patient's condition was too far advanced to be resolved with surgery.
 
Manufacturer Narrative
Dhr review: a full review of the device history record for this device has been carried out with no anomalies identified; product was manufactured and released for sale in accordance with specifications.There is no information to suggest that the device has not met the final release criteria.Ifu review: lombard medical's ifu warns of patient and device selection, and consideration of the risk/benefits with regards to certain characteristics of patient's anatomy.This was an off-label case, and the patient dies of renal failure consequent to contrast nephrotoxicity.Risk analysis review: (b)(6) risk analysis has been reviewed and as this was an off-label case, it doesn ot fall within (b)(6) risk analysis which makes an assumption that the patient has been selected in accordance with the indications and contra-indications for use.The complaints log identifies 8 complaints detailing a patient death.However, these have all been determined not to be device related and were as a result of patient related issues.None of these cases were related to renal failure consequent to contrast nephrotoxicity.(b)(6) has performed over (b)(6) cases to date.The current reported event rate for death is 0.16%.The risk / benefit remains acceptable however lombard medial will continue to track and trend in accordance to quality system procedure.(b)(6) now intends to close this complaint.(internal reference number:(b)(4) mdr#: 3004753364-2015-00015).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AORTIX AAA FLEXIBLE STENT GRAFT SYSTEM
Type of Device
ENDOVASCULAR STENT GRAFT
Manufacturer (Section D)
LOMBARD MEDIAL LTD
didcot, oxfordshire OX11 7HG
UK  OX11 7HG
Manufacturer Contact
4 trident park
didcot, oxfordshire 
235750800
MDR Report Key4837650
MDR Text Key5904190
Report Number3004753364-2015-00015
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
P110032
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 06/10/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/12/2017
Device Model NumberSG-HBB-27-96-63-12
Device Lot NumberCP59307-1
Other Device ID Number01050557156089541717021210CP59
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/28/2015
Initial Date FDA Received06/09/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/01/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death; Hospitalization;
Patient Age85 YR
Patient Weight40
-
-